Century Therapeutics Inc (IPSC) Financials

$1.94

$0.00 (0.00%)

As on 11-Sep-2026 16:00EDT

Market cap

$351 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
Operating Revenue	--	109.16	6.59	2.24	5.20	1.06
Cost of Revenue	29.08	13.10	13.30	13.04	10.07	4.58
Gross Profit	-29.08	96.06	6.59	2.24	5.20	-4.58
Operating Expenses	93.27	111.10	144.73	148.78	139.03	90.30
Operating Profit (EBIT)	-118.80	-15.04	-138.14	-146.55	-133.83	-94.88
Other Income	--	--	--	--	2.99	-0.90
Profit before Tax	-109.86	-9.65	-124.78	-134.79	-130.84	-95.78
Provision for Tax	-0.07	-0.07	1.79	1.88	0.09	0.04
Profit after Tax (Net Income)	-109.79	-9.58	-126.57	-136.67	-130.93	-95.82
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-130.93	-95.82

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
Shareholder's Funds	232.35	158.94	161.36	184.75	302.74	396.24
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	39.59	44.54	62.07	158.10	153.99	25.48
Current Liabilities	15.07	20.23	129.78	17.85	29.82	15.66
Total Liabilities	302.07	223.70	353.22	360.69	486.54	437.38

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
Non-Current Assets	162.24	102.94	159.17	183.70	166.82	209.22
Current Assets	124.77	120.77	194.05	176.99	319.72	228.15
Total Assets	302.07	223.70	353.22	360.69	486.54	437.38
Total Debt*	34.63	43.57	53.83	48.17	49.41	25.12
Net Current Assets	109.70	100.54	64.27	159.15	289.90	212.50

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-103.88	-110.14	-88.35	14.05	-89.00
Cash Flow from Investing Activities	--	107.50	47.48	61.13	-13.13	-298.34
Cash from Financing Activities	--	0.17	74.56	-9.73	27.16	417.77
Net Cash Inflow / Outflow	--	--	--	--	28.08	30.43

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-1.04	-0.11	-1.61	-2.28	-2.24	-1.76
Cash EPS ($)	-0.93	0.04	-1.44	-2.08	-2.10	-1.69
Adjusted Book Value ($)	1.29	1.84	2.05	3.09	5.19	7.27
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.20	-1.40	-1.48	0.24	-1.63
Free Cash Flow per Share ($)	--	-1.21	-1.40	-1.70	-0.28	-2.46

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-4.59	-56.49	-46.72	-33.85	-56.95
ROE (%)	-56.12	-5.98	-73.14	-56.07	-37.46	-66.13
ROA (%)	-36.49	-3.32	-35.46	-32.26	-28.34	-35.22
EBIT Margin (%)	--	-8.84	-1,893.70	-6,006.80	-2,493.58	-8,932.51
Net Margin (%)	--	-8.78	-1,920.87	-6,115.12	-1,598.88	-59,890.00
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	15.57	1.95	-0.57	3.91	--
EBIT Growth (%)	-387.15	92.27	7.06	-3.56	-37.18	-77.66
Net Profit Growth (%)	-371.60	92.43	7.40	-4.38	-36.64	-78.86
EPS Growth (%)	-228.93	0.93	0.29	-0.02	-0.28	-0.37
Book Value Growth (%)	-53.61	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-8.99	-0.63	-1.45	-2.29	-9.02
Price / Book Value	1.50	0.54	0.49	1.08	0.99	2.18
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	131.51	3.64	0.50	-0.61	-0.27	-7.41
Close Price ($)	2.45	0.99	1.01	3.32	5.13	15.86
High Price ($)	3.04	1.19	5.51	5.34	16.83	32.90
Low Price ($)	0.44	0.34	0.95	1.28	4.69	13.08
Market Cap ($ Cr)	351.29	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.27	0.33	0.26	0.16	0.06
Short term debt to equity ratio	--	0.02	0.03	0.01	0.02	0.00
Current Ratio	8.28	5.97	1.50	9.92	10.72	14.57
Quick Ratio	8.28	--	--	--	--	14.59
Interest Coverage	--	--	--	-248.61	-117.32	-74.12

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	0.61	23.07	29.75	15.00	23.63
Asset Turnover	--	0.38	0.02	0.01	0.01	0.00
Receivable days	--	3.66	60.56	118.07	36.18	199.89
Inventory Days	--	--	--	--	-9.07	64.97
Payable days	--	109.40	79.84	114.74	236.65	624.88
Cash Conversion Cycle	--	--	--	--	-209.53	-360.03

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.